the promise of fitusiran for the treatment of patients with hemophilia a and b
Published 2 years ago • 257 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
1:43
the safety and efficacy of fitusiran prophylaxis in patients with hemophilia a and b
-
3:04
fitusiran significantly reduces bleeding events in patients with hemophilia a or b, with inhibitors
-
1:23
the present and future of hemophilia a treatment
-
3:03
insights into the mechanism of action of fitusiran & the value of this agent in hemophilia treatment
-
2:08
an overview of ongoing clinical trials for the treatment of hemophilia
-
4:43
novel treatments being explored for patients with hemophilia: highlights from isth 2024
-
3:29
fitusiran prophylaxis shows encouraging results in hemophilia patients
-
35:00
reverse hemophilia disability, gym diet guide, joint health muscle stretches, faq
-
27:32
chapter 7: treatment of specific hemorrhages
-
41:44
optimizing prophylactic management of hemophilia with novel and emerging non-factor therapies
-
0:39
promising therapeutic options emerging in hemophilia
-
1:05
promising antibodies being explored in hemophilia & a novel diagnostic tool for patients
-
3:49
hope-b trial: etranacogene dezaparvovec shows promise in hemophilia b
-
7:56
guy young: fitusiran for hemophilia a and b with inhibitors
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
4:48
an insight into the management of cytopenias in mf
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:57
a potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
1:51
treatment schedule for ruxolitinib in patients with mpns and how to assess response